Previous consultation responses 

HEART UK regularly responds to consultations on important issues for the charity, including heart disease (both prevention and treatment), cholesterol and familial hypercholesterolaemia (FH). HEART UK seeks clinical input from members of the charity's Medical Scientific and Research Committee and Familial Hypercholesterolaemia Implementation Team.

Recent HEART UK responses are shown below:

NICE: Evolocumab for treating primary hyperlipidaemia and mixed dyslipidaemia - July 2015

Ezetimibe for the treatment of primary (heterozygous - familial and non - familial) hypercholesterolaemia (review of TA132) [ID627] - April 2015

NICE Consultation: Lipid Modification - April 2015

DG2 - Elucigene FH20 and LIPOchip for the diagnosis of FH​ - March 2015

Type 1 Diabetes Update - March 2015

Diabetes in children and young people - March 2015

QOF indicators consultation - February 2015

NHS Health Check Priorities consultation - December 2014

NICE consultation - Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia [ID779]​ - December 2014

NICE consultation - Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease [CG181] - October 2014

NICE consultation - Proposed NICE Health Technology Appraisal: Evolocumab, ezetimibe and lomitapide for treating homozygous familial hypercholesterolaemia [ID810] - August 2014

NICE consultation - Proposed Single Technology Appraisal: Evolocumab, ezetimibe and lomitapide for treating homozygous familial hypercholesterolaemia [ID765] - August 2014

NICE Consultation on updated Lipid Modification guideline - March 2014

NICE consultation on Public Health Guidance Prevention of Cardiovascular Disease (PH25) - January 2014

NICE consultation on potential new indicators for 2015/16 Quality and Outcomes Framework - January 2014

NICE consultation on proposed Public Health Quality Standards topics - December 2013

NICE engagement exercise for Quality Standard on Peripheral Arterial Disease - April 2013

NICE consultation on Familial Hypercholesterolaemia Quality Standard - March 2013

NICE consultation on Clinical Commissioning Group Outcomes Indicator Set - February 2013

NHS Commissioning Board (NHS England) consultation on specialised commissioning - January 2013:

A9c Inherited cardiac conditions

E6a Inherited metabolic disorders (adult)

E6b Inherited metabolic disorders (paediatrics)

Health Committee inquiry into the work of NICE - October 2012

Department of Health consultation for Cardiovascular Disease Outcomes Strategy - September 2012

NICE consultation on Stable Angina Quality Standard - March 2012

NICE consultation on potential new indicators for Quality and Outcomes Framework 2013/14 - February 2012

NICE technology appraisal of Mipomersen for prevention of cardiovascular events - November 2011

National Quality Board Quality Standards engagement exercise - October 2011

NICE review of Clinical Guideline CG71 - Identification and management of Familial Hypercholesterolaemia - July 2011